HCPCS Level II · unclassified
J0612 — Injection, calcium gluconate, not otherwise specified, 10 mg
In short
J0612 is the HCPCS Level II code for injection, calcium gluconate, not otherwise specified, 10 mg: drugs with no specific code of their own. It has no fixed drug or unit, so the claim carries the NDC of the drug given and its quantity.
Code
CMS HCPCS file- Descriptor
- Injection, calcium gluconate, not otherwise specified, 10 mg
- Short descriptor
- Inj, calcium gluconate, nos
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Apr 1, 2024
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under J0612
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 24 NDCs to J0612 for Calcium Gluconate. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Calcium Gluconate | 00143-9180-25 | Hikma Pharmaceuticals USA Inc. | 25 × 10 | 2,500 |
| Calcium Gluconate | 00143-9184-25 | Hikma Pharmaceuticals USA Inc. | 25 × 50 | 12,500 |
| Calcium Gluconate | 00143-9185-20 | Hikma Pharmaceuticals USA Inc. | 20 × 100 | 20,000 |
| Calcium Gluconate | 00404-9764-10 | Henry Schein Inc. | 10 | 100 |
| Calcium Gluconate | 00404-9831-10 | Henry Schein Inc. | 10 | 100 |
| Calcium Gluconate | 00404-9831-50 | Henry Schein Inc. | 50 | 500 |
| Calcium Gluconate | 51662-1312-01 | HF Acquisition Co. LLC, DBA HealthFirst | 10 | 100 |
| Calcium Gluconate | 63323-0360-19 | FreseniUS Kabi USA, LLC | 25 × 10 | 2,500 |
| Calcium Gluconate | 63323-0360-59 | FreseniUS Kabi USA, LLC | 25 × 50 | 12,500 |
| Calcium Gluconate | 63323-0360-61 | FreseniUS Kabi USA, LLC | 20 × 100 | 20,000 |
| Calcium Gluconate | 65219-0162-10 | FreseniUS Kabi USA, LLC | 24 × 50 | 2,400 |
| Calcium Gluconate | 65219-0164-50 | FreseniUS Kabi USA, LLC | 24 × 100 | 4,800 |
| Calcium Gluconate | 65219-0630-19 | FreseniUS Kabi USA, LLC | 25 × 10 | 2,500 |
| Calcium Gluconate | 70069-0727-10 | Somerset Pharma, LLC | 10 × 50 | 5,000 |
| Calcium Gluconate | 70069-0727-25 | Somerset Pharma, LLC | 25 × 50 | 12,500 |
| Calcium Gluconate | 70069-0728-20 | Somerset Pharma, LLC | 20 × 100 | 20,000 |
| Calcium Gluconate | 75834-0171-19 | Nivagen Pharmaceuticals, Inc. | 25 × 10 | 2,500 |
| Calcium Gluconate | 80830-1672-02 | Amneal Pharmaceuticals, LLC | 10 × 10 | 1,000 |
| Calcium Gluconate | 80830-1673-02 | Amneal Pharmaceuticals, LLC | 10 × 50 | 5,000 |
| Calcium Gluconate | 80830-1674-02 | Amneal Pharmaceuticals, LLC | 10 × 100 | 10,000 |
| Calcium Gluconate | 80830-2362-02 | Amneal Pharmaceuticals, LLC | 12 × 50 | 1,200 |
| Calcium Gluconate | 80830-2362-09 | Amneal Pharmaceuticals Private Limited | 24 × 50 | 2,400 |
| Calcium Gluconate | 80830-2363-02 | Amneal Pharmaceuticals, LLC | 12 × 100 | 2,400 |
| Calcium Gluconate | 80830-2363-09 | Amneal Pharmaceuticals Private Limited | 24 × 100 | 4,800 |
J0612: common questions
- Is J0612 a CPT code?
- No. J0612 is a HCPCS Level II code, maintained by CMS, that identifies a drug with no specific code of its own. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDC goes with J0612?
- None is fixed. J0612 is used for drugs that have no specific HCPCS code, so the claim carries the NDC of the drug actually given and its quantity, and payers usually also ask for the drug name and dose. How to find a J-code.
- What is the Medicare payment limit for J0612?
- $0.024 per 10 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.